4 assets in Demyelinating Disease

Therapeutic assets addressing Demyelinating Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pittsburgh Compound B Unlabelled Demyelinating Disease	Yale University	P2	B (60)
ER-176 Demyelinating Disease	Mayo Clinic	P2	CCC (53)
[ 18f]3f4ap Demyelinating Disease	Yale University	P1	CC (43)
mk-6240 Demyelinating Disease	Yale University	P1	CC (43)